NUZ

NEURITHERA FPO [NUZ]
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Healthcare · ASX Small Cap
$0.0640 -1.5%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when NUZ triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track NUZ — Free

Active Signals

Bullish Signals

  • MACD momentum is losing steam
  • Drifting lower — down 3.0% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
  • Critical cash runway (1.8 quarters)
  • Moderate P/S ratio (8.6x)
  • Strong revenue growth (+290%)
  • Near 52-week low (8% of range)
  • Small-cap ($20-100M)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 54% over the past year
  • Revenue growing at +290% — the top line is moving in the right direction
  • RBA hiking (-3pts)
  • Calendar: Quarterly 4C in 13d (+5pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Deeply negative margins (-248%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about NUZ
"What's driving NUZ today?" "How does NUZ compare to peers?" "Key risks for NUZ?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE HEALEY Enrolment Complete - Topline Accelerated to Q2 CY27
NONE Application for quotation of securities - NUZ
NONE Notification of cessation of securities - NUZ

Recent ASX Announcements

2026-07-16 HEALEY Enrolment Complete - Topline Accelerated to Q2 CY27 PRICE SENSITIVE
2026-07-16 Application for quotation of securities - NUZ
2026-07-14 Notification of cessation of securities - NUZ
2026-07-01 Neurizon Invites Investors to Melbourne Briefing
2026-06-30 Change of Director's Interest Notice

Key Metrics

$51.2M
Market Cap
1.1M
Avg Volume
0.9x
Vol Ratio
$0.06 — $0.18
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-147.1%
ROE
-248.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 52%
LLeader vs LaggardlaggardRS: -13
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:NUZ vs IDTNUZ vs ADRNUZ vs LDX
Scout Pro — Deeper Analysis for NUZ
Try Pro free for 30 days
Share this analysis

Track NUZ and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required